Varty K, Allen K E, Jones L, Sayers R D, Bell P R, London N J
Department of Surgery, University of Leicester, UK.
Br J Surg. 1994 Jun;81(6):819-22. doi: 10.1002/bjs.1800810609.
An organ culture of human saphenous vein was used as a model of vein graft intimal hyperplasia and the potential of Losartan, an angiotensin II receptor antagonist, to inhibit neointimal proliferation was investigated. Median (range) neointimal thickness was reduced from 17 (16-19) to 11 (8-18) microns in veins cultured with Losartan (median difference 5 (95 per cent confidence interval 2-8) microns). A similar decrease in the median neointimal proliferation index was seen from 21 (range 14-47) to 15 (range 5-31) per cent (median difference 8 per cent (95 per cent confidence interval 5-11 per cent)). These results demonstrate that angiotensin II receptor antagonists may be of therapeutic value for the modulation of vein graft intimal hyperplasia.
用人隐静脉的器官培养物作为静脉移植物内膜增生的模型,研究了血管紧张素II受体拮抗剂氯沙坦抑制内膜增生的潜力。在用氯沙坦培养的静脉中,内膜厚度中位数(范围)从17(16 - 19)微米降至11(8 - 18)微米(中位数差异为5(95%置信区间2 - 8)微米)。内膜增生指数中位数也有类似下降,从21%(范围14 - 47%)降至15%(范围5 - 31%)(中位数差异为8%(95%置信区间5 - 11%))。这些结果表明,血管紧张素II受体拮抗剂可能对调节静脉移植物内膜增生具有治疗价值。